184 related articles for article (PubMed ID: 25196646)
1. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses.
Bunse CE; Fortmeier V; Tischer S; Zilian E; Figueiredo C; Witte T; Blasczyk R; Immenschuh S; Eiz-Vesper B
Clin Exp Immunol; 2015 Feb; 179(2):265-76. PubMed ID: 25196646
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
[TBL] [Abstract][Full Text] [Related]
3. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy.
Schillingmann DA; Riese SB; Vijayan V; Tischer-Zimmermann S; Schmetzer H; Maecker-Kolhoff B; Blasczyk R; Immenschuh S; Eiz-Vesper B
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678050
[TBL] [Abstract][Full Text] [Related]
6. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.
Pfirrmann V; Oelsner S; Rettinger E; Huenecke S; Bonig H; Merker M; Wels WS; Cinatl J; Schubert R; Klingebiel T; Bader P
Cytotherapy; 2015 Aug; 17(8):1139-51. PubMed ID: 26072027
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
9. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M
J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
11. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
[TBL] [Abstract][Full Text] [Related]
12. Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.
Burt TD; Seu L; Mold JE; Kappas A; McCune JM
J Immunol; 2010 Nov; 185(9):5279-88. PubMed ID: 20921523
[TBL] [Abstract][Full Text] [Related]
13. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.
Popescu I; Pipeling MR; Shah PD; Orens JB; McDyer JF
J Immunol; 2014 Dec; 193(11):5709-5722. PubMed ID: 25339676
[TBL] [Abstract][Full Text] [Related]
14. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21.
Luo XH; Meng Q; Liu Z; Paraschoudi G
Clin Immunol; 2020 Aug; 217():108456. PubMed ID: 32376504
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells cross-talk with tumour antigen-specific CD8
Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
[TBL] [Abstract][Full Text] [Related]
16. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
17. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.
Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC
Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409
[TBL] [Abstract][Full Text] [Related]
19. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
20. CMV-specific TCR-transgenic T cells for immunotherapy.
Schub A; Schuster IG; Hammerschmidt W; Moosmann A
J Immunol; 2009 Nov; 183(10):6819-30. PubMed ID: 19864595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
